These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Testosterone deficiency syndrome among males with type 2 diabetes mellitus in East Malaysia. Ahmad S; Jerampang P; Tohid H; Ali MF; Jamil TR; Kong CHC Nagoya J Med Sci; 2020 Nov; 82(4):613-621. PubMed ID: 33311792 [TBL] [Abstract][Full Text] [Related]
3. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort. Anderson SG; Heald A; Younger N; Bujawansa S; Narayanan RP; McCulloch A; Jones H Prim Care Diabetes; 2012 Jul; 6(2):143-8. PubMed ID: 21982717 [TBL] [Abstract][Full Text] [Related]
4. Relationship between serum magnesium concentration and metabolic and hormonal disorders in middle-aged and older men. Rotter I; Kosik-Bogacka D; Dołęgowska B; Safranow K; Karakiewicz B; Laszczyńska M Magnes Res; 2015; 28(3):99-107. PubMed ID: 26507751 [TBL] [Abstract][Full Text] [Related]
5. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus. Ogbera OA; Sonny C; Olufemi F; Wale A J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405 [TBL] [Abstract][Full Text] [Related]
6. Impact of hypertension, overall obesity and abdominal obesity on diabetes incidence in Shanghai residents with different glucose levels. Qian Q; Li X; Feng B Diabetes Res Clin Pract; 2012 Jun; 96(3):e59-62. PubMed ID: 21906830 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Kapoor D; Aldred H; Clark S; Channer KS; Jones TH Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552 [TBL] [Abstract][Full Text] [Related]
8. Male hypogonadism. Part I: Epidemiology of hypogonadism. Seftel AD Int J Impot Res; 2006; 18(2):115-20. PubMed ID: 16193071 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study. de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246 [TBL] [Abstract][Full Text] [Related]
10. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. Ogbera AO West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833 [TBL] [Abstract][Full Text] [Related]
11. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi). Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867 [TBL] [Abstract][Full Text] [Related]
12. Hypogonadism, erectile dysfunction, and type 2 diabetes mellitus: what the clinician needs to know. Tamler R; Deveney T Postgrad Med; 2010 Nov; 122(6):165-75. PubMed ID: 21084793 [TBL] [Abstract][Full Text] [Related]
13. Left ventricular filling pressure in male patients with type 2 diabetes and normal versus low total testosterone levels. Tinetti M; Gysel M; Farias J; Ferrer M; Lombardero M; Baranchuk A Cardiol J; 2015; 22(2):206-11. PubMed ID: 25179319 [TBL] [Abstract][Full Text] [Related]
14. Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular diseases. Li H; Kong XB; Zhang HL; Wu J J Sex Med; 2011 Apr; 8(4):1260. PubMed ID: 20561165 [No Abstract] [Full Text] [Related]
15. Prevalence and risk factors of hypogonadism in men with chronic renal failure. Oueslati I; Ounissi M; Talbi E; Azaiez S; Bacha MM; Ben Abdallah T Tunis Med; 2020 Feb; 98(2):138-143. PubMed ID: 32395803 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension. Marcadenti A; Fuchs SC; Moreira LB; Wiehe M; Gus M; Fuchs FD Am J Hypertens; 2011 Feb; 24(2):175-80. PubMed ID: 20885370 [TBL] [Abstract][Full Text] [Related]
17. Hypogonadotropic hypogonadism in men with type 2 diabetes. Dandona P; Dhindsa S; Chandel A; Chaudhuri A Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease. Dhindsa S; Reddy A; Karam JS; Bilkis S; Chaurasia A; Mehta A; Raja KP; Batra M; Dandona P Eur J Endocrinol; 2015 Sep; 173(3):359-66. PubMed ID: 26101371 [TBL] [Abstract][Full Text] [Related]
19. [EFFECTIVE SCREENING METHODS FOR CARBOHYDRATE METABOLISM DISORDERS]. Velichko VI; Said OV; Astvatsatrian G R ; Karpinska TL Lik Sprava; 2015; (1-2):169-70. PubMed ID: 26118068 [TBL] [Abstract][Full Text] [Related]
20. [Applying a directed acyclic graph (DAG): testosterone as a risk factor for development of type 2 diabetes mellitus in the study of health in Pomerania (SHIP)]. Schipf S Gesundheitswesen; 2011 Dec; 73(12):906-8. PubMed ID: 22193903 [No Abstract] [Full Text] [Related] [Next] [New Search]